Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.4B | 2.4B | 2.4B | 2.5B |
Cost of revenue | 830M | 792M | 704M | 769M |
Gross profit | 1.6B | 1.7B | 1.7B | 1.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 66M | 63M | 50M | 60M |
Other operating expenses | — | — | — | — |
Operating income | 1.5B | 1.6B | 1.7B | 1.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 534M | 558M | 498M | 534M |
Other income expense | — | — | — | — |
Pretax income | 159M | 2.0B | 562M | -20M |
Tax provision | 157M | 44M | 91M | -97M |
Net income | 2M | 2.0B | 471M | 77M |
Basic EPS | 0 | 4.0 | 1.0 | 0.2 |
Diluted EPS | 0 | 4.0 | 1.0 | 0.2 |
Basic average shares | 492.4M | 492.4M | 492.4M | 492.6M |
Diluted average shares | 492.4M | 492.4M | 492.4M | 492.6M |
EBITDA | 1.3B | 1.7B | 1.7B | 1.1B |
Net income from continuing op. | 1.6B | 1.7B | 1.7B | 1.8B |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |